WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VRDN

Based on 7 analysts offering 12 month price targets for Viridian Therapeutics Inc.
Min Forecast
$25.00+71.23%
Avg Forecast
$34.43+135.82%
Max Forecast
$40.00+173.97%

Should I buy or sell VRDN stock?

Based on 7 analysts offering ratings for Viridian Therapeutics Inc.
Buy
Strong Buy
1 analysts 14.29%
Buy
6 analysts 85.71%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VRDN stock forecasts and price targets.

VRDN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2023-12-19
RBC Capital
Top 3%
98
BuyReiterates$35.00+139.73%2023-12-14
JMP Securities
Top 24%
77
BuyMaintains$38.00+160.27%2023-11-14

1 of 1

Forecast return on equity

Is VRDN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is VRDN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VRDN revenue forecast

What is VRDN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$325.0k+3.5%
Avg 2 year Forecast
$14.0M+4,363.69%
Avg 3 year Forecast
$74.0M+23,453.5%
VRDN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VRDN revenue growth forecast

How is VRDN forecast to perform vs Biotechnology companies and vs the US market?
Company
504.64%
Industry
38.03%
Market
10.06%
VRDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VRDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VRDN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VRDN$14.60$34.43+135.82%Buy
BCRX$4.43$11.00+148.31%Strong Buy
ZNTL$12.96$33.75+160.42%Strong Buy
IMNM$15.48$34.00+119.64%Strong Buy
MDXG$6.29$12.67+101.38%Strong Buy
View Top Biotech Stocks

Viridian Therapeutics Stock Forecast FAQ

Is Viridian Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: VRDN) stock is to Buy VRDN stock.

Out of 7 analysts, 1 (14.29%) are recommending VRDN as a Strong Buy, 6 (85.71%) are recommending VRDN as a Buy, 0 (0%) are recommending VRDN as a Hold, 0 (0%) are recommending VRDN as a Sell, and 0 (0%) are recommending VRDN as a Strong Sell.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.

What is VRDN's revenue growth forecast for 2024-2026?

(NASDAQ: VRDN) Viridian Therapeutics's forecast annual revenue growth rate of 504.64% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Viridian Therapeutics's revenue in 2024 is $314,000.On average, 2 Wall Street analysts forecast VRDN's revenue for 2024 to be $20,399,460, with the lowest VRDN revenue forecast at $18,830,271, and the highest VRDN revenue forecast at $21,968,650. On average, 3 Wall Street analysts forecast VRDN's revenue for 2025 to be $879,750,261, with the lowest VRDN revenue forecast at $21,968,650, and the highest VRDN revenue forecast at $2,554,640,099.

In 2026, VRDN is forecast to generate $4,642,163,942 in revenue, with the lowest revenue forecast at $1,620,030,982 and the highest revenue forecast at $9,263,237,981.

What is VRDN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VRDN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VRDN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year VRDN price target, the average VRDN price target is $34.43, with the highest VRDN stock price forecast at $40.00 and the lowest VRDN stock price forecast at $25.00.

On average, Wall Street analysts predict that Viridian Therapeutics's share price could reach $34.43 by Mar 21, 2025. The average Viridian Therapeutics stock price prediction forecasts a potential upside of 135.82% from the current VRDN share price of $14.60.

What is VRDN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VRDN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.